Observational Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Apr 26, 2020; 8(8): 1444-1453
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1444
Table 1 Subject characteristics, preoperative medications, and baseline mean arterial pressure (n = 10)
CaseAge (yr)Weight (kg)Height (cm)BMIG/PGA (wk)Preoperative medication(s)DiagnosisB-MAP (mmHg)
1379817432.41/039Magnesium sulfateSevere PE107
2398415634.56/236Magnesium sulfateSevere PE117
3289216135.52/033LabetalolSevere PE128
4309316733.32/038Labetalol, magnesium sulfateMild PE99
5408916034.85/137Labetalol, magnesium sulfateMild PE76
6369016831.93/132Labetalol, magnesium sulfateSevere PE129
7319016234.31/034LabetalolSevere PE125
84384.516431.43/135Magnesium sulfateSevere PE109
9398116828.74/232Nicardipine, magnesium sulfateSevere PE126
10358016031.23/033Magnesium sulfateSevere PE113
Table 2 Main hemodynamic variables by time interval for all patients (mean ± SD) (n = 10)
Time pointCO
CVP
HR
MAP
SV
SVR
MeanSDMeanSDMeanSDMeanSDMeanSDMeanSD
T17.20.86.74.784.618.8115.917.986.518.11233.7246.1
T26.717.85.784.716.6117.616.781.423.11336.3321.5
T370.98.44.58614.6110.614.584.623.91183.3242.3
T47.50.98.76.184.614.8113.221.691.122.51133.9277.6
T57.61.28.45.281.915.6108.519.89323.71081.2285.8
T67.518.55.184.318.110818.192.725.41077.5250.4
T77.518.3583.313.9107.520.291.124.71078.3256.1
T87.31.283.782.117.1107.620.591.824.21129.9397.1
T97.31.59.84.380.916.2100.221.593.527.21031.1268.3
T107.21.810.24.481.712.1101.521.590.728.21072.8319.9
T11a8.61.79.24.596.310.891.3a20.891.419807.5a280.9
T11b7.91.210.73.988.211.697.519.189.619893.6189.8
T11c819.53.48712.394.822.393.618.1856.0a202.1
T127.41.38.23.580.91698.812.594.226.21008.1211.9